Strategic Plan 2030

Towards ultra-individualisation in oncology
Frise Banner: 
Strategic Plan 2030

Strategic Plan 2030 

Focused, instrumental multidisciplinary research

To bring together the best that science has to offer and to closely connect medical, scientific and industrial experts in a bid to promote rapid research that impacts society by mobilising data, cutting-edge technologies and a culture of curiosity, persistence and openness.

The Gustave Roussy 2030 Plan - a new scientific strategy shaping the next 10 years – is revolutionising its research based on an anticipation of preventing cancer and controlling it more effectively. 

Rely on inductive, interdisciplinary and collaborative research

Co-founded by Sanofi, Inserm, the Institut Polytechnique de Paris [Paris Polytechnic Institute] and the Paris-Saclay University, the Paris Saclay Cancer Cluster combines optimum interdisciplinary expertise and biotechnology within a high-potential ecosystem. Around ten innovative projects and major trials will be selected each year within this prospective oncology centre and all oncology stakeholders are invited to participate.

Increased collaboration between doctors, researchers, industrialists and start-ups should facilitate and encourage more technological and collaborative structured research exploring new disciplines (Maths, Physics, Human and Social Sciences, etc.), educational fields and professions. A cross-synergy for the benefit of concrete innovations: therapeutic solutions based on microbiota, stem cells or molecular analysis of Rare Circulating Cells.

Generate research to directly benefit patients

This research, which is linked as closely as possible to Gustave Roussy patients, will have greater impact in transforming care and treatment in the future. Ten major, flag-ship medical and scientific programmes have been launched as part of the strategic plan and are geared to this objective. From childhood cancers (Crescendo) to an understanding of the mechanisms of resistance to innovative therapies, they call on the latest advances (profiling of samples analysed on high-throughput platforms, biomarkers, etc.) and give patients - adults and children alike - early access to large cohorts (Canto) and sound scientific advances.

The university hospital research projects (UHR), heralding the future and symbolising this concentration of expertise, also reflect the ambition of individualised, more targeted and less invasive research.

Catégorie de la page: